Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
Shah, Neil P., Skaggs, Brian J., Branford, Susan, Hughes, Timothy P., Nicoll, John M., Paquette, Ronald L., Sawyers, Charles L.Volume:
117
Language:
english
Journal:
Journal of Clinical Investigation
DOI:
10.1172/JCI30890
Date:
September, 2007
File:
PDF, 925 KB
english, 2007